Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
Clinical trial NCT03895463 · WITHDRAWN
Trial details
- NCT number
- NCT03895463
- Sponsor
- Ipsen
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-01
- Primary completion
- 2023-03-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.